Suppr超能文献

具有不同内在活性的苯二氮䓬受体配体可改变非嗜酒(NP)大鼠的乙醇摄入量。

Benzodiazepine receptor ligands with different intrinsic efficacies alter ethanol intake in alcohol-nonpreferring (NP) rats.

作者信息

June H L, Murphy J M, Hewitt R L, Greene T L, Lin M, Mellor-Burke J J, Lumeng L, Li T K

机构信息

Department of Psychology, Indianapolis, IN 46202-3275, USA.

出版信息

Neuropsychopharmacology. 1996 Jan;14(1):55-66. doi: 10.1016/S0893-133X(96)80059-5.

Abstract

Benzodiazepine (BDZ) receptor ligands with varying intrinsic efficacies [RO19-4603, 0.02-0.15 mg/kg; FG 7142 1-16 mg/kg; DMCM, 1-8 mg/kg; RO16-6028 (bretazenil), 8-32 mg/kg] in modulating GABAergic activity were examined for the ability to alter palatability-induced ethanol (EtOH) intake in the alcohol-nonpreferring (NP) line of rats. NP rats on a 22-hour fluid-deprivation schedule were given 2-hour daily access to a 10% (v/v) EtOH/3% (g/v) polycose solution and water. Average EtOH intake was 2.1 +/- 0.2 g/kg/2 hours, and water intake was 17.1 +/- 0.9 ml/2 hours. During the initial 15 minutes of the 2-hour session, RO19-4603, the imidazothienodiazepine partial inverse agonist reduced EtOH intake to 19% of control values at 0.04 mg/kg and completely suppressed drinking of the EtOH solution at 0.15 mg/kg. Twenty-four-hour postdrug administration, the 0.08-mg/kg dose of RO19-4603 completely suppressed drinking of the EtOH solution at the 60-minute interval, and the 0.15-mg/kg dose reduced intake to 20% of control levels at the 15-minute interval. FG 7142, the partial beta-carboline inverse agonist reduced EtOH drinking at the 60-minute interval with the 1-mg/kg dose, and the 16-mg/kg dose reduced water intake at the 15-minute interval. DMCM, the full beta-carboline inverse agonist, significantly reduced water intake at 15 minutes (4 and 8 mg/kg), and the same doses caused a substantial increase in EtOH drinking at the 120-minute interval. The anxiolytic agent bretazenil (16 and 32 mg/kg) increased EtOH consumption during the initial 15 minutes to 270% to 425% of control levels, and water intake increased by the end of the 2-hour session to as much as 210% of control following administration of the 32-mg/kg dose. These findings support existing evidence suggesting that BDZ receptor ligands may modify neuronal processes that mediate some reinforcing and/or aversive properties of alcohol. They further demonstrate a potential importance of the GABAA-BDZ receptor complex in mediating palatability- (environmentally) induced EtOH drinking even in rats selectively bred for low alcohol preference.

摘要

研究了具有不同内在活性的苯二氮䓬(BDZ)受体配体[RO19 - 4603,0.02 - 0.15毫克/千克;FG 7142,1 - 16毫克/千克;DMCM,1 - 8毫克/千克;RO16 - 6028(布瑞氮䓬),8 - 32毫克/千克]调节GABA能活性的能力,以考察其改变酒精非偏好(NP)品系大鼠中适口性诱导的乙醇(EtOH)摄入的能力。处于22小时液体剥夺方案的NP大鼠每天有2小时可获取10%(v/v)乙醇/3%(g/v)聚葡萄糖溶液和水。平均乙醇摄入量为2.1±0.2克/千克/2小时,水摄入量为17.1±0.9毫升/2小时。在2小时实验期的最初15分钟内,咪唑并噻吩二氮䓬部分反向激动剂RO19 - 4603在0.04毫克/千克时将乙醇摄入量降至对照值的19%,在0.15毫克/千克时完全抑制了乙醇溶液的饮用。给药后24小时,0.08毫克/千克剂量的RO19 - 4603在60分钟间隔时完全抑制了乙醇溶液的饮用,0.15毫克/千克剂量在15分钟间隔时将摄入量降至对照水平的20%。部分β-咔啉反向激动剂FG 7142在1毫克/千克剂量时在60分钟间隔减少了乙醇饮用,16毫克/千克剂量在15分钟间隔减少了水摄入。完全β-咔啉反向激动剂DMCM在15分钟时显著减少了水摄入(4和8毫克/千克),相同剂量在120分钟间隔时导致乙醇饮用大幅增加。抗焦虑药布瑞氮䓬(16和32毫克/千克)在最初15分钟内将乙醇消耗量增加至对照水平的270%至425%,在给予32毫克/千克剂量后,在2小时实验期结束时水摄入量增加至对照的高达210%。这些发现支持了现有证据,表明BDZ受体配体可能改变介导酒精某些强化和/或厌恶特性的神经元过程。它们进一步证明了GABAA - BDZ受体复合物在介导适口性(环境)诱导的乙醇饮用中的潜在重要性,即使在为低酒精偏好而选择性培育的大鼠中也是如此。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验